Trial Profile
Phase 3 Multi-Center Double-Blind Randomized Placebo-Controlled Effectiveness and Safety Study to Assess the Role of Truvada in Preventing HIV Acquisition in Women.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2022
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections; HIV-2 infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms FEM-PrEP
- 24 Aug 2020 Results of a comprehensive model analysis using data from following clinical studies: HPTN082, VOICE trial, HPTN035, FEM-PrEP, ASPIRE, ECHO trials for estimation of HIV incidences and interventions effectiveness published in the JAIDS
- 10 Mar 2016 Results of a sub-group analysis from kenyan participants (n=62) published in the Contraception
- 11 Jul 2012 Results published in the New England Journal of Medicine.